Home
Resources
Diseases
Training
SYSVAC
About
Registry
E-learning courses
News
Events
Network
Vision and Mission
Steering Committee
Map
Meetings
Join us
Home
Resources
Resources
Selected
NITAG documentation
SAGE documentation
Newborn
Clear all
Type of publications
NITAG documentation
(8)
SAGE documentation
(3)
Systematic reviews (SYSVAC)
(290)
Topics
GRADE table
(3)
Recommendation
(8)
Regions
Africa
(1)
Americas
(1)
Europe
(6)
Countries
Belgium
(1)
Canada
(1)
France
(2)
Luxembourg
(1)
Niger
(1)
Spain
(2)
Diseases
COVID-19
(1)
Hepatitis B
(1)
Influenza
(3)
Malaria
(1)
Meningococcal disease
(3)
Pneumococcal disease
(3)
Publication date
2023
(1)
2022
(4)
2020
(1)
2019
(1)
2015
(3)
Target population
Newborn
(11)
Adolescents
(6)
Adults
(8)
All age groups
(1)
Children
(23)
Healthcare workers
(6)
Migrants
(1)
Pregnant women
(9)
Risk group
(9)
Available to download in languages
English (EN)
(4)
French (FR)
(4)
Spanish (ES)
(2)
11 results found
2023
∙
NACI
Interim guidance on the use of pneumococcal 15-valent conjugate vaccine (PNEU-C-15) in pediatric populations
2022
Vaccination recommendations against flu in children aged 6 to 59 months
2022
Vaccination recommendations against flu in children aged 6 to 59 months
2022
∙
Conseil Supérieur de la Santé (CSS)
Vaccination against COVID-19 with mRNA vaccines for children from 6 months of age in Belgium
2022
Niger-NITAG advice on the introduction of the malaria vaccine in routine immunization
2020
∙
Haute Autorité de Santé
Maintaining vaccination for newborn babies in the context of the COVID-19 pandemic
2019
∙
Conseil Supérieur des Maladies Infectieuses
recommendations concerning the vaccination of children born prematurely
2015
∙
SAGE
Duration of protection conferred by MenA conjugate vaccination in immunocompetent children (3 to 24 months of age) against serogroup A meningococcal disease
2015
∙
SAGE
Efficacy of a two dose schedule of MenA conjugate vaccination in immunocompetent children (3 to 9 months of age) against serogroup A meningococcal disease
2015
∙
SAGE
Safety of MenA conjugate vaccination in immunocompetent children (3 to 24 months of age)
Home
Resources
Diseases
Training
SYSVAC
News
Events
Network
Sign in / Register